Skip to content
TrialScanner

NCT01174732

Dose-Ranging Study of A006 DPI, in Adult Asthma Patients

Phase 2CompletedAMPHLead

Registry record

Lead sponsor
Amphastar Pharmaceuticals, Inc.
Conditions
Asthma; Bronchospasm
Primary completion
Oct 2010Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01174732 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01174732: Dose-Ranging Study of A006... | TrialScanner